Ginseng in Decreasing Cancer-Related Fatigue After Treatment in Cancer Survivors
NCT03407716 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 2
Last updated 2023-01-05
Summary
This randomized pilot trial studies how well North American ginseng extract AFX-2 (ginseng) works in decreasing cancer-related fatigue after treatment in cancer survivors. Ginseng may decrease fatigue in people who were treated for cancer.
Conditions
- Cancer Survivor
- Stage I Breast Cancer AJCC v7
- Stage I Colon Cancer AJCC v6 and v7
- Stage IA Breast Cancer AJCC v7
- Stage IB Breast Cancer AJCC v7
- Stage II Breast Cancer AJCC v6 and v7
- Stage II Colon Cancer AJCC v7
- Stage IIA Breast Cancer AJCC v6 and v7
- Stage IIA Colon Cancer AJCC v7
- Stage IIB Breast Cancer AJCC v6 and v7
- Stage IIB Colon Cancer AJCC v7
- Stage IIC Colon Cancer AJCC v7
- Stage III Breast Cancer AJCC v7
- Stage III Colon Cancer AJCC v7
- Stage IIIA Breast Cancer AJCC v7
- Stage IIIA Colon Cancer AJCC v7
- Stage IIIB Breast Cancer AJCC v7
- Stage IIIB Colon Cancer AJCC v7
- Stage IIIC Breast Cancer AJCC v7
- Stage IIIC Colon Cancer AJCC v7
Interventions
- DRUG
-
American Ginseng
Given PO
- OTHER
-
Laboratory Biomarker Analysis
Correlative studies
- OTHER
-
Placebo
Given PO
- OTHER
-
Questionnaire Administration
Correlative studies
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH - lead OTHER
Principal Investigators
-
Noel Arring · Mayo Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-01
- Primary Completion
- 2020-05-13
- Completion
- 2021-02-22
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
American Ginseng for the Prevention of Moderate-severe Fatigue in Breast Cancer Patients
NCT03730298 ·Status: UNKNOWN ·Phase: NA
-
Cancer-related Fatigue in Patients With Breast Cancer Treatment With Zhengyuan Capsules
NCT06381557 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer
NCT00005805 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety and Efficacy of Redsenol-1 Plus on Cancer-related Fatigue in Adults
NCT05664009 ·Status: RECRUITING ·Phase: PHASE2
-
Thymosin-α1 in Cancer-Related Fatigue
NCT02127268 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Efficacy of ALC in Breast Cancer in Subjects With Fatigue
NCT00555841 ·Status: TERMINATED ·Phase: PHASE2
-
Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer
NCT01958372 ·Status: COMPLETED ·Phase: PHASE1
-
Study With Modafinil in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer (MOTIF)
NCT00917748 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of PG2 on Fatigue-Related Symptom Clusters
NCT02740959 ·Status: COMPLETED ·Phase: NA
-
Developmental Study on Fatigue in Cancer
NCT00034450 ·Status: COMPLETED ·Phase: PHASE2
-
Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer
NCT01330446 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Epoetin Alfa in Treating Fatigue in Patients With Advanced Solid Tumors Who Are Not Receiving Chemotherapy
NCT00052221 ·Status: WITHDRAWN ·Phase: NA
-
Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors
NCT06819254 ·Status: RECRUITING ·Phase: PHASE4
-
Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal Cancers
NCT05722288 ·Status: RECRUITING ·Phase: PHASE2
-
Modafinil in Treating Fatigue in Patients Receiving Chemotherapy for Cancer
NCT00042848 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients
NCT00516269 ·Status: TERMINATED ·Phase: PHASE3
-
Melatonin Supplementation for Cancer-related Fatigue in Patients Receiving Radiotherapy
NCT02332928 ·Status: TERMINATED ·Phase: PHASE3
-
Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal or Gynecological Cancer
NCT06855524 ·Status: RECRUITING ·Phase: PHASE2
-
Modafinil in Treating Fatigue in Patients With Cancer
NCT00112515 ·Status: UNKNOWN ·Phase: NA
-
Dextromethorphan in Treating Patients With Fatigue Caused by Cancer
NCT00176540 ·Status: TERMINATED ·Phase: NA
-
Modafinil in Cancer Related Fatigue
NCT01440621 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy and Tolerability of Modafinil for Fatigue and Daytime Sleepiness in Cancer Patients: Preliminary Study
NCT02385656 ·Status: UNKNOWN ·Phase: PHASE4
-
PG2 Treatment for Improving Fatigue Among Advanced Cancer Patients Under Standard Palliative Care
NCT01720550 ·Status: COMPLETED ·Phase: PHASE4
-
Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer
NCT03563352 ·Status: WITHDRAWN
-
The Effect of Melatonin Supplementation on Fatigue Symptoms During Chemotherapy Treatment of Breast Cancer Patients
NCT06125353 ·Status: COMPLETED ·Phase: NA